3Dimensions System User Guide
Chapter 1: Introduction
MAN-05085-002 Revision 002
Page 3
DRAFT
Preview Copy-Generated May 30, 2018
1.5
More Information About Tomosynthesis
The Hologic Selenia Dimensions system received FDA approval for the Hologic
Tomosynthesis option on 11 Feb 2011 (refer to PMA number P080003). This FDA
approval applies to screening and diagnostic imaging. More information is available
from the FDA website at
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P080003
.
The Generated 2D option (C-View) in conjunction with Tomosynthesis received FDA
approval on 16 May 2013 (refer to PMA number P080003 S001). More information is
available from the FDA website at
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P080003S001
.
A list of scientific publications about Breast Tomosynthesis is available from the Hologic
website. The majority of the studies were done with the commercially released Hologic
Selenia Dimensions Tomosynthesis system. See the publication at
http://www.hologic.com/sites/default/files/Tomo-Bibliography-Rev-13.pdf
.
The Hologic website has several white papers and summary cards about breast imaging
publications. See the documents at
http://www.hologic.com/en/learning-center/white-
papers/breastimaging/
.
Independent publications have examined Hologic Selenia Dimensions Tomosynthesis
systems in population-based screening sequences in Europe. Results consistently show a
significant increase in invasive cancer detection rate at the same time as a reduction in
false positives. The following publications are recommended.
Integration of 3D digital mammography with tomosynthesis for population breast-
cancer screening (STORM): a prospective comparison study.
Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, Tuttobene P,
Bricolo P, Fantò C, Valentini M, Montemezzi S, Macaskill P.
Lancet Oncol. 2013 Jun;14(7):583-9. doi: 10.1016/S1470-2045(13)70134-7. Epub 2013 Apr 25.
http://www.ncbi.nlm.nih.gov/pubmed/23623721
Prospective trial comparing full-field digital mammography (FFDM) versus
combined FFDM and tomosynthesis in a population-based screening programme
using independent double reading with arbitration.
Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, Izadi M, Jebsen IN,
Jahr G, Krager M, Hofvind S.
Eur Radiol. 2013 Aug;23(8):2061-71. doi: 10.1007/s00330-013-2820-3. Epub 2013 Apr 4.
http://www.ncbi.nlm.nih.gov/pubmed/23553585
